The Medicines Patent Pool released its 2017 prioritization report today selecting five HIV and two hepatitis C compounds for potential licensing agreements. The annual medicines priority report, traditionally reviewing MPP’s target list for HIV, this year expands to important treatments […]
Related Content:
VIDEO: Discussion – Priorities for communities of people living with HIV in Canada and globally March 10, 2017 Javier Bellocq (GNP+) and Christian Hui (CPPN) share key outcomes of the 3rd Positive Leadership Summit (LIVING 2016) held in Durban at AIDS 2016 and leading concerns and priorities moving…- 6th Canadian Symposium on Hepatitis C Virus (CSHCV) January 27, 2017 The Canadian Symposium on Hepatitis C Virus, organised by CanHepC, has been taking place each year since 2012. This one day meeting brings together Canadian and international scientists, clinicians, young…
- Updated Training Manual for Treatment Advocates: Hepatitis C Virus and Coinfection with HIV [Treatment Action Group – TAG] February 1, 2018 The purpose of this Training Manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and…
- There’s Great News — And Grim News — In The Fight Against HIV/AIDS July 28, 2017 [goats and soda - NPR] By Natalie Jacewicz - For the first time, more than half of the 36.7 million people with HIV have access to treatment. That means most people with…
Young women are left out of HIV/AIDS victories October 30, 2017 This blog first appeared on the Huffington Post.By Lebogang Motsumi I was first diagnosed with HIV eight years ago, and only then did I notice that every year, the international…- NAFTA will undermine health unless Canada resists monopolies on medicines February 5, 2018 By Nicholas Caivano and Richard Elliott, The Star - Time and again, Canadians reaffirm their belief in the basic principle of equitable access to health care for all. But the spirit…